ID
16778
Description
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of Study: Results - IHC
Lien
https://clinicaltrials.gov/ct2/show/NCT00373425
Mots-clés
Versions (2)
- 07/08/2016 07/08/2016 -
- 17/09/2021 17/09/2021 -
Téléchargé le
7 août 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
IHC Results, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
IHC Results, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Description
IHC Results
Description
Block Specimen
Type de données
integer
Alias
- UMLS CUI [1]
- C1533157
Description
Specimen
Type de données
integer
Alias
- UMLS CUI [1]
- C0444330
Description
Date received
Type de données
date
Alias
- UMLS CUI [1,1]
- C1514756
- UMLS CUI [1,2]
- C0011008
Description
Number
Type de données
integer
Description
Technician
Type de données
text
Alias
- UMLS CUI [1]
- C1556020
Description
IHC Result
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0021044
- UMLS CUI [1,2]
- C1274040
Description
EGFR membrane staininig in tumor cells
Type de données
float
Unités de mesure
- %
Alias
- UMLS CUI [1,1]
- C0034802
- UMLS CUI [1,2]
- C1704680
- UMLS CUI [1,3]
- C0597032
Description
Intensity of membrane staining
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0034802
- UMLS CUI [1,2]
- C1704680
- UMLS CUI [1,3]
- C0597032
- UMLS CUI [1,4]
- C0522510
Description
Percentage of cells displaying the highest intensity of membrane staining
Type de données
float
Unités de mesure
- %
Alias
- UMLS CUI [1,1]
- C0034802
- UMLS CUI [1,2]
- C1704680
- UMLS CUI [1,3]
- C0597032
- UMLS CUI [1,4]
- C0522510
Description
Membrane staining
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0034802
- UMLS CUI [1,2]
- C1704680
- UMLS CUI [1,3]
- C0597032
- UMLS CUI [1,4]
- C0007603
- UMLS CUI [1,5]
- C0205197
Description
Cytoplasmic staining
Type de données
float
Unités de mesure
- %
Alias
- UMLS CUI [1,1]
- C0034802
- UMLS CUI [1,2]
- C1704680
- UMLS CUI [1,3]
- C0597032
- UMLS CUI [1,4]
- C0010834
Description
Additional Comments
Type de données
text
Alias
- UMLS CUI [1]
- C1830770
Description
Pathologist Signature
Type de données
text
Alias
- UMLS CUI [1,1]
- C1519316
- UMLS CUI [1,2]
- C0334866
Description
Report Date
Type de données
date
Alias
- UMLS CUI [1]
- C1302584
Similar models
IHC Results, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0600091 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C1704680 (UMLS CUI [1,2])
C0597032 (UMLS CUI [1,3])
C1704680 (UMLS CUI [1,2])
C0597032 (UMLS CUI [1,3])
C0522510 (UMLS CUI [1,4])
C1704680 (UMLS CUI [1,2])
C0597032 (UMLS CUI [1,3])
C0522510 (UMLS CUI [1,4])
C1704680 (UMLS CUI [1,2])
C0597032 (UMLS CUI [1,3])
C0007603 (UMLS CUI [1,4])
C0205197 (UMLS CUI [1,5])
C1704680 (UMLS CUI [1,2])
C0597032 (UMLS CUI [1,3])
C0010834 (UMLS CUI [1,4])
C0334866 (UMLS CUI [1,2])